Critical congenital heart disease (CCHD) is a category of congenital heart disease that includes a range of disorders requiring intervention soon after birth. Screening consists of measuring the oxygen saturation (as a reflection of hypoxemia) by using a pulse oximeter in the right hand as well as either foot. Babies who screen positive do not necessarily have CCHD, as other conditions can also lead to low oxygen saturation. Diagnostic testing for CCHD includes echocardiogram and cardiac catheterization. Primary treatment is usually surgical. CCHD includes the following conditions: hypoplastic left heart syndrome, pulmonary atresia, truncus arteriosus, total anomalous pulmonary venous connection, d-transposition of the great arteries, tetralogy of Fallot, and tricuspid atresia.
| Condition:1 | Critical congenital heart disease | 
|---|---|
| Abbreviation:1 | CCHD | 
| Category:2 | Core | 
| SNOMED CT Code:3 | 61959006—Common arterial trunk (truncus
                  arteriosus) 26146002—Complete transposition of great
                  vessels 204342004—Congenital atresia of pulmonary
                  valve 13213009—Congenital heart disease 204354004—Congenital tricuspid atresia and
                  stenosis 62067003—Hypoplastic left heart syndrome
                 204456001—Subdiaphragmatic total anomalous
                  pulmonary venous return 204457005—Supradiaphragmatic total
                  anomalous pulmonary venous return 86299006—Tetralogy of Fallot 204297006—Total great vessel transposition
                 | 
| ICD-9-CM Code:5 | 746.01—Atresia of pulmonary valve,
                congenital 745.0—Common truncus 745.10—Complete transposition of great
                vessels 746.7—Hypoplastic left heart syndrome 745.2—Tetralogy of fallot 747.41—Total anomalous pulmonary venous
                connection 746.1—Tricuspid atresia and stenosis,
                congenital | 
| ICD-10-CM Code:6 | Q20.0—Common arterial trunk Q22.4—Congenital tricuspid stenosis Q20.3—Discordant ventriculoarterial
                connection Q23.4—Hypoplastic left heart syndrome Q22.0—Pulmonary valve atresia Q21.3—Tetralogy of Fallot Q26.2—Total anomalous pulmonary venous
                connection | 
These measurements are associated with the condition:
| LOINC Long Common Name10 | Analyte Short Name11 | LOINC Number12 | Units13 | 
|---|---|---|---|
| CCHD newborn screening interpretation | 73700-7 | Answer list | |
| CCHD newborn screening protocol used [Type] | CCHD protocol | 73697-5 | |
| Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal | Pre-post difference | 73696-7 | % | 
| Oxygen saturation in Blood Postductal by Pulse oximetry | Postductal O2 sat | 59418-4 | % | 
| Oxygen saturation in Blood Preductal by Pulse oximetry | Preductal O2 sat | 59407-7 | % | 
Additional information is available from the Online Mendelian Inheritance in Man (OMIM®)14:
 (OMIM 217095)
(OMIM 217095) (OMIM 241550)
(OMIM 241550) (OMIM 614435)
(OMIM 614435) (OMIM 265150)
(OMIM 265150) (OMIM 187500)
(OMIM 187500) (OMIM 106700)
(OMIM 106700) (OMIM 608808)
(OMIM 608808) (OMIM 613853)
(OMIM 613853) (OMIM 613854)
(OMIM 613854) (OMIM 605067)
(OMIM 605067)Table — Code mapping table for representative CCHD conditions across standard terminologies.
| Condition | CDC/BPA code15 | ICD-9-CM code5 | ICD-10-CM code6 | SNOMED CT code3 | STS/IPCCC code16 | 
|---|---|---|---|---|---|
| Hypoplastic Left Heart Syndrome | 746.70 | 746.7 | Q23.4 | 62067003 | 730 | 
| Pulmonary Atresia | 746.00 | 746.01 | Q22.0 | 204342004 | 330 | 
| Truncus Arteriosus | 745.00 | 745.0 | Q20.0 | 61959006 | 160 | 
| Total Anomalous Pulmonary Venous Connection (TAPVC/TAPVR) | 747.42 | 747.41 | Q26.2 | 111323005 | 200 | 
| d-Transposition of the Great Arteries | 745.10 | 745.10 | Q20.3 | 26146002, 204297006 | 880 | 
| Tetralogy of Fallot | 745.2 | 745.2 | Q21.3 | 86299006 | 290 | 
| Tricuspid Atresia | 746.100 | 746.1 | Q22.4 | 204354004 | 390 | 
Legend
Condition Name and Abbreviation — curated by the NLM and selected from among the names used by the Advisory Committee on Heritable Disorders in Newborns and Children (Committee), National Newborn Screening Information System (NNSIS), the American College of Medical Genetics (ACMG), the HHS Office of the National Coordinator for Health Information Technology (ONC)/American Health Information Community (AHIC) Personalized Health Care Work Group, and input from the newborn screening community.
Category — based on the U.S. Department of Health and Human Services (HHS) Recommended Uniform Screening Panel. Conditions designated as "core" should be included in every newborn screening program, and "secondary" conditions are some of the disorders that may be detected during screening for a core disorder. Conditions classified as "other" are those that are screened for by some states but are not part of the Recommended Uniform Screening Panel.
SNOMED CT® Code — Systematized Nomenclature of Medicine — Clinical Terms code is assigned by the International Health Terminology Standards Development Organisation (IHTSDO). SNOMED CT is a concept-oriented clinical terminology that has been designated as a U.S. standard for electronic health information exchange. The Newborn Screening Coding and Terminology Guide uses some codes from the US Extension to SNOMED CT.
UMLS CUI — a concept unique identifier (CUI) assigned to every concept in the Unified Medical Language System (UMLS®).
ICD-9-CM Code — International Classification of Diseases, Ninth Revision, Clinical Modification code is assigned to diagnoses associated with hospital utilization in the U.S. It is a current US standard for use in administrative healthcare transactions. Although ICD-9-CM codes are fairly specific, in certain cases, the same ICD-9-CM code might apply to several disorders in the same group (e.g. amino acid disorders).
ICD-10-CM Code — International Classification of Diseases, Tenth Revision, Clinical Modification code. Although ICD-10-CM codes are fairly specific, in certain cases, the same ICD-10-CM code might apply to multiple related disorders.
Enzyme Commission (EC) Number —
            a unique identifier for the affected enzyme (if the affected protein is an enzyme); the EC number is
            assigned by the Recommendations of the Nomenclature Committee of the
              International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of
              Enzymes by the Reactions they Catalyse .
.
UniProt Number — a unique identifier assigned to all proteins, including
            enzymes, hemoglobin subunits, and immunoglobulin chains. The UniProt database is maintained by the Universal Protein
              Resource , an international collaboration.
, an international collaboration.
Affected Protein — the structure that is abnormal in this condition. The affected protein could be an enzyme, a hormone, or a specific molecule such as hemoglobin or immunoglobulin chain. If the affected protein is an enzyme, it will have an Enzyme Commission (EC) number.
LOINC Long Common Name — derived by the Logical Observation
              Identifiers Names and Codes (LOINC®) Committee from the measurement's formal name by using
            conventional names for analytes and procedures. The long common name eliminates the parts of the formal name
            that are not needed to distinguish the test from related tests.
 (LOINC®) Committee from the measurement's formal name by using
            conventional names for analytes and procedures. The long common name eliminates the parts of the formal name
            that are not needed to distinguish the test from related tests.
Analyte Short Name — an abbreviation for the analyte.
LOINC Number — the unique and permanent code assigned by the Logical Observation
              Identifiers Names and Codes (LOINC®) Committee to identify the test measurement.
            LOINC codes are unique for different test methods and different units of reporting to enable
            interoperability and comparison of results from different labs. LOINC is a U.S. government standard for
            electronic health information exchange of laboratory tests and other measurements in Interoperability
            Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).
 (LOINC®) Committee to identify the test measurement.
            LOINC codes are unique for different test methods and different units of reporting to enable
            interoperability and comparison of results from different labs. LOINC is a U.S. government standard for
            electronic health information exchange of laboratory tests and other measurements in Interoperability
            Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).
Units — what is being counted or measured, using the Unified Code for
              Units of Measure (UCUM). Ratios whose units fully cancel each other are indicated
            by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not
            quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such
            as "Pos or Neg" or "Specific alleles").
 (UCUM). Ratios whose units fully cancel each other are indicated
            by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not
            quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such
            as "Pos or Neg" or "Specific alleles").
OMIM — Online Mendelian Inheritance in Man® is a comprehensive resource about human genes and genetic
            diseases. It focuses primarily on the relationship between genotype and phenotype. It is currently
            maintained by Johns Hopkins University.
 is a comprehensive resource about human genes and genetic
            diseases. It focuses primarily on the relationship between genotype and phenotype. It is currently
            maintained by Johns Hopkins University.
CDC/BPA — The Centers for Disease Control and Prevention/ British Paediatric Association (CDC/BPA) codes are unique codes developed by the CDC for tracking birth defects. The codes stem from ICD-9-CM with modifications based on BPA terminology.
STS/IPCCC — The Society of Thoracic Surgeons' (STS) codes and International Pediatric and Congenital Cardiac Codes (IPCCC) are specific codes for cardiac lesions. IPCCC uses detailed, multi-axial coding to capture the full details of the lesion. IPCCC codes are encouraged for use in cardiac research by the National Heart, Lung, and Blood Institute. STS codes are more general codes that were based on the fine-grained IPCCC codes. STS codes are used to record patient diagnoses in the STS Congenital Heart Surgery Database.